Success Metrics

Active Trials
9(100%)

Phase Distribution

Ph phase_2
4
44%
Ph phase_1
5
56%

Phase Distribution

5

Early Stage

4

Mid Stage

0

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
5(55.6%)
Phase 2Efficacy & side effects
4(44.4%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

9

trials recruiting

Total Trials

9

all time

Status Distribution
Active(9)

Detailed Status

Recruiting9

Development Timeline

Analytics

Development Status

Total Trials
9
Active
9
Success Rate
N/A
Most Advanced
Phase 2

Trials by Phase

Phase 15 (55.6%)
Phase 24 (44.4%)

Trials by Status

recruiting9100%

Recent Activity

9 active trials
Showing 5 of 9
recruitingphase_2

A Phase II Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumour[Substudy 04]

NCT07390383
recruitingphase_1

A Clinical Trial of LBL-024 Combined With Etoposide and Platinum in Patients With Advanced Neuroendocrine Carcinoma

NCT06157827
recruitingphase_2

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]

NCT07111546
recruitingphase_2

A Phase II Clinical Study of LBL-024 Combination Therapy in Patients With Advanced Solid Tumour[Substudy 03(ESCC)]

NCT07331155
recruitingphase_1

A Phase Ib/Ⅱ Clinical Trial of LBL-024 Combined With Paclitaxel in Patients With Platinum-resistant Ovarian Cancer

NCT07042802
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT07390383Phase 2

A Phase II Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumour[Substudy 04]

Recruiting
NCT06157827Phase 1

A Clinical Trial of LBL-024 Combined With Etoposide and Platinum in Patients With Advanced Neuroendocrine Carcinoma

Recruiting
NCT07111546Phase 2

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]

Recruiting
NCT07331155Phase 2

A Phase II Clinical Study of LBL-024 Combination Therapy in Patients With Advanced Solid Tumour[Substudy 03(ESCC)]

Recruiting
NCT07042802Phase 1

A Phase Ib/Ⅱ Clinical Trial of LBL-024 Combined With Paclitaxel in Patients With Platinum-resistant Ovarian Cancer

Recruiting
NCT07281976Phase 1

A Trial of LBL-024 Monotherapy or Combination Drug in Patients With Triple Negative Breast Cancer

Recruiting
NCT06783647Phase 2

A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 01(NSCLC)]

Recruiting
NCT07099430Phase 1

A Trial of LBL-024 Monotherapy, LBL-024 Combined With LBL-007 or Toripalimab in Patients With Advanced Melanoma

Recruiting
NCT05170958Phase 1

A Phase I/II Clinical Study of LBL-024 in Patients With Advanced Malignant Tumors

Recruiting

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9